To elucidate the role of these pathways in the tumorigenesis of NSCLC, we have determined the protein expression levels of key players in NSCLC, including EGFR, pAKT, pERK, and p53, as prognostic biomarkers in early-stage NSCLC. This evidence concerns the gene EIF2AK3 and non-small cell lung carcinoma.